Skip to main content
Home
Zeitschriften
Zeitungen
Podcast
Gesundheitspolitik
Praxis
Allerlei
Jobs
Fachgebiete
Allgemeinmedizin Anästhesiologie & Intensivmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kinder & Jugendheilkunde Neurologie & Psychiatrie Orthopädie & Unfallchirurgie Pflege Urologie Zahnmedizin Apotheke
Subfächer Innere Medizin
Diabetologie Gastroenterologie Infektiologie Kardiologie Onkologie und Hämatologie Pneumologie Rheumatologie
Fortbildungen
Überblick Fortbildungen DFP-Literaturstudium-Artikel DFP-Webcast Fortbildungen DFP-Podcasts
Erweiterte Suche
Anmelden
nach oben
Spektrum der Augenheilkunde

02.02.2024 | themenschwerpunkt

Uveitis posterior

verfasst von: Dr.med. univ. Beate Wegscheider, FEBO

Erschienen in: Spektrum der Augenheilkunde

Einloggen, um Zugang zu erhalten

Zusammenfassung

Dieser Artikel bietet einen Überblick über Ursachen und Verläufe von infektöser und nicht-infektöser Uveitis posterior. Er hilft bei der Erstellung von Differenzialdiagnosen und zeigt Therapieoptionen auf.
Literatur
1.
Aaberg TM. Recurrences and bilaterality in the multiple evanescent white-dot syndrome. Am J Ophthalmol. 1985;100(1):29–37.PubMedCrossRef
2.
Abu-Yaghi NE. White dot syndromes: a 20-year study of incidence, clinical features, and outcomes. Ocul Immunol Inflamm. 2011;19(6):426–30.PubMedPubMedCentralCrossRef
3.
Ahnood D. Punctate inner choroidopathy: a review. Surv Ophthalmol. 2017;62(2):113–26.PubMedCrossRef
4.
Akpek EK. Successful treatment of serpiginous choroiditis with alkylating agents. Ophthalmology. 2002;109(8):1506–13.PubMedCrossRef
5.
Akpek EK. New treatments for serpiginous choroiditis. Curr Opin Ophthalmol. 2003;14(3):128–31.PubMedCrossRef
6.
7.
8.
Baglivo E. Multiple evanescent white dot syndrome after hepatitis B vaccine. Am J Ophthalmol. 1996;122(3):431–2.PubMedCrossRef
9.
10.
11.
Brézin AP. HLA-A29 and birdshot chorioretinopathy. Ocul Immunol Inflamm. 2011;19(6):397–400.PubMedCrossRef
12.
Brown J. Visual prognosis of multifocal choroiditis, punctate inner choroidopathy, and the diffuse subretinal fibrosis syndrome. Ophthalmology. 1996;103(7):1100–5.PubMedCrossRef
13.
Butler NJ. Ocular toxoplasmosis II: clinical features, pathology and management. Clin Exp Ophthalmol. 2013;41(1):95–108.PubMedCrossRef
14.
Callanan D. Multifocal choroiditis and choroidal neovascularization associated with the multiple evanescent white dot and acute idiopathic blind spot enlargement syndrome. Ophthalmology. 1992;99(11):1678–85.PubMedCrossRef
15.
Cao JH. Birdshot chorioretinitis lesions on Indocyanine green angiography as an indicator of disease activity. Retina. 2006;36(9):1751–7.CrossRef
16.
Channa R. Characterization of macular lesions in punctate inner choroidopathy with spectral domain optical coherence tomography. J Ophthalmic Inflamm Infect. 2012;2(3):113–20.PubMedPubMedCentralCrossRef
17.
Christmas NJ. Long-term follow-up of patients with serpinginous choroiditis. Retina. 2002;22(5):550–6.PubMedCrossRef
18.
19.
dell’Omo R. Multiple evanescent white dot syndrome (MEWDS). Int Ophthalmol Clin. 2012;52(4):221–8.PubMedCrossRef
20.
21.
Elkins BS. Ocular toxoplasmosis misdiagnosed as cytomegalovirus retinopathy in immunocompromised patients. Ophthalmology. 1994;101(3):499–507.PubMedCrossRef
22.
Essilfie J. Are there two forms of multiple evanescent white dot syndrome? Retina. 2022;42:227–35.PubMedCrossRef
23.
Gass JD. Acute posterior multifocal placoid pigment epitheliopathy. Arch Ophthalmol. 1968;80(2):177–85.PubMedCrossRef
24.
Gass JD. Acute zonal occult outer retinopathy: a long-term follow-up study. Am J Ophthalmol. 2002;134(3):329–39.PubMedCrossRef
25.
Gelfman S. ERAP1, ERAP2, and two copies of HLA-aw19 alleles increase the risk for birdshot chorioretinopathy in HLA-A29 carriers. Invest Ophthalmol Vis Sci. 2021;62(14):3.PubMedPubMedCentralCrossRef
26.
Grigg ME. Unusual abundance of atypical strains associated with human ocular toxoplasmosis. J Infect Dis. 2001;184(5):633–9.PubMedCrossRef
27.
28.
Hangai M. Features and function of multiple evanescent white dot syndromw. Arch Ophthalmol. 2009;127(10):1307–13.PubMedCrossRef
29.
Holak HM. The pathogenesis of birdshot chorioretinopathy. Surv Ophthalmol. 2006;51(4):446–7.PubMedCrossRef
30.
Holland GN. Ocular toxoplasmosis: a global reassessment. Part II: disease manifestations and management. Am J Ophthalmol. 2004;137(1):1–17.MathSciNetPubMed
31.
32.
Jabs DA. Cytomegalovirus retinitis and the acquired immunodeficiency syndrome—bench to bedside: LXVII Edward Jackson Memorial Lecture. Am J Ophthalmol. 2011;151(2):198–216.e1.PubMedCrossRef
33.
Jampol LM. Multiple evanescent white dot syndrome. I. Clinical findings. Arch Ophthalmol. 1984;102(5):671–4.PubMedCrossRef
34.
Jampol LM. White spot syndromes of the retina: a hypothesis based on the common genetic hypothesis of autoimmune/inflammatory disease. Am J Ophthalmol. 2003;135(3):376–9.PubMedCrossRef
35.
36.
Kuiper JJ. A genome-wide association study identifies a functional ERAP2 haplotype associated with birdshot chorioretinopathy. Hum Mol Genet. 2014;23(22):6081–7.PubMedPubMedCentralCrossRef
37.
Kuo IC. Clinical characteristics and outcomes of cytomegalovirus retinitis in persons without human immunodeficiency virus infection. Am J Ophthalmol. 2004;138(3):338–46.PubMedCrossRef
38.
39.
Labalette P. Ocular toxoplasmosis after the fifth decade. Am J Ophthalmol. 2002;133(4):506–15.PubMedCrossRef
40.
Langner-Wegscheider BJ. Intravitreal ganciclovir in the management of non-AIDS-related human cytomegalovirus retinitis. Can J Ophthalmol. 2010;45(2):157–60.PubMedCrossRef
41.
Li D. Loss of photoreceptor outer segment in acute zonal occult outer retinopathy. Arch Ophthalmol. 2007;125(9):1194–200.PubMedCrossRef
42.
43.
Monnet D. Longitudinal cohort study of patients with birdshot chorioretinopathy. I. Baseline clinical characteristics. Am J Ophthalmol. 2006;141(1):135–42.PubMedCrossRef
44.
Monnet D. Longitudinal cohort study of patients with birdshot chorioretinopathy. III. Macular imaging at baseline. Am J Ophthalmol. 2007;144(6):818–28.PubMedCrossRef
45.
46.
Mrejen S, et al. Choroidal involvement in acute posterior multifocal placoid pigment epitheliopathy. Ophthalmic Surg Lasers Imaging Retina. 2016;47(1):20–6.PubMedCrossRef
47.
Munteanu G. Serpiginous choroiditis—clinical study. Oftalmologia. 2001;52(2):72–80.PubMed
48.
Muthiah MN. Acute retinal necrosis: a national population-based study to assess the incidence, methods of diagnosis, treatment strategies and outcomes in the UK. Br J Ophthalmol. 2007;91(11):1452–5.PubMedPubMedCentralCrossRef
49.
50.
51.
52.
Schoenberger SD. Diagnosis and treatment of acute retinal necrosis: a report by the American academy of ophthalmology. Ophthalmology. 2017;124(3):382–92.PubMedCrossRef
53.
54.
Silveira C. The effect of long-term intermittent trimethoprim/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis. Am J Ophthalmol. 2002;134(1):41–6.PubMedCrossRef
55.
Soheilian M. Randomized trial of intravitreal clindamycin and dexamethasone versus pyrimethamine, sulfadiazine, and prednisolone in treatment of ocular toxoplasmosis. Ophthalmology. 2011;118(1):134–41.PubMedCrossRef
56.
Standardization of Uveitis Nomenclature (SUN) Working Group. Classification criteria for acute posterior multifocal placoid pigment epitheliopathy. Am J Ophthalmol. 2021;228:174–81.CrossRef
57.
Standardization of Uveitis Nomenclature (SUN) Working Group. Classification criteria for acute retinal necrosis syndrome. Am J Ophthalmol. 2021;228:237–44.CrossRef
58.
Standardization of Uveitis Nomenclature (SUN) Working Group. Classification criteria for Behçet disease uveitis. Am J Ophthalmol. 2021;228:80–8.CrossRef
59.
Standardization of Uveitis Nomenclature (SUN) Working Group. Classification criteria for cytomegalovirus retinitis. Am J Ophthalmol. 2021;228:245–54.CrossRef
60.
Standardization of Uveitis Nomenclature (SUN) Working Group. Classification criteria for multiple evanescent white dot syndrome. Am J Ophthalmol. 2021;228:198–204.CrossRef
61.
Standardization of Uveitis Nomenclature (SUN) Working Group. Classification criteria for punctate inner choroiditis. Am J Ophthalmol. 2021;228:275–80.CrossRef
62.
Standardization of Uveitis Nomenclature (SUN) Working Group. Classification criteria for sarcoidosis-associated uveitis. Am J Ophthalmol. 2021;228:220–30.CrossRef
63.
Standardization of Uveitis Nomenclature (SUN) Working Group. Classification criteria for serpiginous choroiditis. Am J Ophthalmol. 2021;228:126–33.CrossRef
64.
Standardization of Uveitis Nomenclature (SUN) Working Group. Classification criteria for syphilitic uveitis. Am J Ophthalmol. 2021;228:182–91.CrossRef
65.
Standardization of Uveitis Nomenclature (SUN) Working Group. Classification criteria for toxoplasmic retinitis. Am J Ophthalmol. 2021;228:134–41.CrossRef
66.
67.
Steiner S, et al. Imaging in the diagnosis and management of APMPPE. Int Ophthalmol Clin. 2012;52(4):211–9.PubMedCrossRef
68.
Thomas BC. Ocular outcome and frequency of neurological manifestations in patients with acute posterior multifocal placoid pigment epitheliopathy (APMPPE). J Ophthalmic Inflamm Infect. 2012;2(3):125–31.PubMedPubMedCentralCrossRef
69.
Thorne JE. Loss of visual field among patients with birdshot chorioretinopathy. Am J Ophthalmol. 2008;145(1):23–8.PubMedCrossRef
70.
Urzua CA. Vogt-Koyanagi-Harada disease: the step-by-step approach to a better understanding of clinicopathology, immunopathology, diagnosis, and management: a brief review. J Ophthal Inflamm Infect. 2022;12(1):17.CrossRef
71.
72.
Weiss H. The clinical course of serpiginous choroidopathy. Am J Ophthalmol. 1979;87(2):133–42.PubMedCrossRef
73.
Workowski KA. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015;64(RR-03):1–137.PubMed
74.
75.
Xu Y. Presumed recurrent MEWDS following Covid-19 vaccination. Ocul Immunol Inflamm. 2021;29(6):1234–7.PubMedCrossRef
76.
Yap SC. Syphilitic uveitis in a Singaporean population. Ocul Immunol Inflamm. 2014;22(1):9–14.PubMedCrossRef
77.
Zhang X. Spectral-domain optical coherence tomographic findings at each stage of punctate inner choroidopathy. Ophthalmology. 2012;120(12):2678–83.CrossRef
Metadaten
Titel
Uveitis posterior
verfasst von
Dr.med. univ. Beate Wegscheider, FEBO
Publikationsdatum
02.02.2024
Verlag
Springer Vienna
Erschienen in
Spektrum der Augenheilkunde
Print ISSN: 0930-4282
Elektronische ISSN: 1613-7523
DOI
https://doi.org/10.1007/s00717-023-00566-9